Lupin gets USFDA approval to market Tetrabenazine tablets
Lupin has received final approval to market its Tetrabenazine tablets, from the US health regulator. It is used for treating involuntary movements associated with Huntington’s disease....
Tag : Lupin
Lupin Outlook for the Week (Apr 23, 2018 – Apr 27, 2018)
EquityPandit’s Outlook for Lupin for the week (Apr 23, 2018 – Apr 27, 2018) : LUPIN: Lupin closed the week on positive note gaining around 2.60%....
Lupin Outlook for the Week (Apr 16, 2018 – Apr 20, 2018)
EquityPandit’s Outlook for Lupin for the week (Apr 16, 2018 – Apr 20, 2018) : LUPIN: Lupin closed the week on negative note losing around 3.60%....
Lupin Outlook for the Week (Apr 09, 2018 – Apr 13, 2018)
EquityPandit’s Outlook for Lupin for the week (Apr 09, 2018 – Apr 13, 2018) : LUPIN: Lupin closed the week on positive note gaining around 10.00%....
Lupin gets EIR for Pithampur unit, from USFDA
Lupin has received the establishment investigation report (EIR) for the successful inspection of its Pithampur, Unit 1, from USFDA. The inspection was carried out during July...
Lupin Outlook for the Week (Apr 02, 2018 – Apr 06, 2018)
EquityPandit’s Outlook for Lupin for the week (Apr 02, 2018 – Apr 06, 2018) : LUPIN: Lupin closed the week on positive note gaining around 0.20%....
Lupin Outlook for the Week (Mar 26, 2018 – Mar 28, 2018)
EquityPandit’s Outlook for Lupin for the week (Mar 26, 2018 – Mar 28, 2018) : LUPIN: Lupin closed the week on negative note losing around 3.70%....
Lupin gets USFDA approval for Tydemy tablets
Lupin has launched Tydemy tablets, which is suggested to be used by women for contraception. The company in a statement said that, the launch follows the...
Lupin Outlook for the Week (Mar 12, 2018 – Mar 16, 2018)
EquityPandit’s Outlook for Lupin for the week (Mar 12, 2018 – Mar 16, 2018) : LUPIN: Lupin closed the week on negative note losing around 4.90%....
Lupin Outlook for the Week (Mar 05, 2018 – Mar 09, 2018)
EquityPandit’s Outlook for Lupin for the week (Mar 05, 2018 – Mar 09, 2018) : LUPIN: Lupin closed the week on negative note losing around 0.50%....